Alternatives to Histrelin If You Can't Fill Your Prescription

Histrelin (Supprelin LA) is a highly effective, once-yearly implant for central precocious puberty (CPP). But what happens if your specialty pharmacy doesn't have it in stock, your insurance denies coverage, or access is delayed for another reason? The good news is that several alternative GnRH agonist medications are FDA-approved for CPP — and for adults with prostate cancer who were previously on Vantas, there are effective options there too.

Important: Do not switch medications without speaking to your prescribing physician. All GnRH agonists work through the same basic mechanism, but dosing, administration, monitoring, and insurance coverage vary significantly. Your doctor needs to evaluate what's right for your specific situation.

GnRH Agonist Alternatives for Central Precocious Puberty (CPP)

Five GnRH agonists are currently FDA-approved for pediatric CPP in the United States. Histrelin (Supprelin LA) is one of them. Here are the others:

Leuprolide Acetate (Lupron Depot-Ped) — Most Widely Used Alternative

Leuprolide acetate (brand name Lupron Depot-Ped) is the most commonly prescribed GnRH agonist for CPP in the United States. It is available as a monthly (7.5 mg, 11.25 mg, or 15 mg) or every-3-month (11.25 mg or 30 mg) intramuscular injection. Lupron Depot-Ped has the most extensive long-term safety and efficacy data of any GnRH agonist. It is more widely stocked than Supprelin LA and available through a broader range of specialty pharmacies.

The trade-off compared to Histrelin is that Lupron requires injections every 1–3 months rather than a once-yearly procedure. For families who prefer to avoid frequent clinic visits and injections, Histrelin's annual implant is often preferred — but when Histrelin access is a barrier, Lupron is the most established fallback.

Triptorelin (Triptodur) — 6-Month Injection

Triptorelin pamoate (brand name Triptodur) was FDA-approved in 2017 for CPP as a 6-month intramuscular injection. It strikes a middle ground between Lupron's frequent injections and Histrelin's annual procedure — requiring just two injections per year. Triptodur has shown similar efficacy to Lupron in suppressing pubertal hormones.

Like Lupron Depot-Ped, Triptodur requires a standard IM injection — no surgical procedure. However, it has less long-term follow-up data than Lupron since it is a newer formulation. It is manufactured by Arbor Pharmaceuticals, giving it an independent supply chain from Lupron.

Leuprolide Acetate (Fensolvi) — 6-Month Subcutaneous Injection

Fensolvi was FDA-approved in 2020. It is a 6-month subcutaneous (under-skin) injection of leuprolide acetate, unlike Lupron Depot-Ped which is intramuscular. Subcutaneous injections are generally less painful than intramuscular injections, making Fensolvi a more comfortable option for some children. Like Triptodur, it requires just two injections per year.

38,224+ patients found their medications in stock

38K+

Find Histrelin In Stock Today →

Nafarelin Acetate (Synarel) — Intranasal Option

Nafarelin acetate (Synarel) is an intranasal GnRH agonist administered as a nasal spray twice daily. It avoids injections entirely, which can be appealing — but adherence is a significant concern since it requires consistent daily administration. It is still FDA-approved and available, but less commonly used due to adherence challenges compared to longer-acting options.

Alternatives for Prostate Cancer (Vantas Was Discontinued)

Since Vantas (histrelin for prostate cancer) was permanently discontinued in September 2021, patients with advanced prostate cancer must use other androgen deprivation therapy options. These include:

[@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop The most commonly used GnRH agonist for prostate cancer. Monthly or 3-month IM depot injections.

[@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop A subcutaneous implant (monthly or 3-month) from a different manufacturer.

[@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop Monthly or 3-month IM injection.

[@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop A GnRH antagonist — no testosterone flare at the start of therapy.

[@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop An oral GnRH antagonist — once-daily pill, no injections.

Skip the calls, skip the stress.

Find Histrelin In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

How to Choose: Key Differences at a Glance

All FDA-approved GnRH agonists for CPP have similar efficacy for hormone suppression — the choice often comes down to frequency of administration, insurance coverage, and patient preference:

Histrelin (Supprelin LA): Annual implant — maximum convenience, but requires a minor surgical procedure

Triptodur / Fensolvi: Every 6 months — good middle ground

Lupron Depot-Ped: Monthly or every 3 months — most data, most flexible dosing

Synarel: Twice daily intranasal spray — avoids injections but adherence is challenging

If you need help locating any of these medications at a pharmacy near you, medfinder can call pharmacies on your behalf to find which ones have your medication in stock.

Talk to Your Doctor Before Switching

Switching GnRH agonists is not something you should do on your own. Your doctor will need to evaluate the appropriate alternative, adjust dosing if necessary, and update insurance prior authorizations. If Histrelin access issues are related to a supply problem, read our article on the Histrelin shortage update for 2026 for more context.